MedPath

Diverting ileostomy after low anterior resectio

Completed
Conditions
Histologically verified and operable rectal cancer
Cancer
Registration Number
ISRCTN15655996
Lead Sponsor
Brothers of Mercy Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
210
Inclusion Criteria

1. Patients aged 19 to 85 years with biopsy-proven and operable rectal cancer
2. Patients with or without preoperative radio-chemotherapy
3. Patients with a distal border of the tumour within 16 cm from the anal verge as demonstrated by rigid rectoscopy
4. Patients with a WHO performance status = 2

Exclusion Criteria

1. Patients with previous rectal surgery
2. Emergency cases
3. Planned laparoscopic resections
4. Patients suffering from metastatic disease or synchronous colon cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary efficacy endpoint of the present study was the overall anastomotic leakage rate as defined by one of the following: <br>1. Radiologic leak: radiologic evidence of a leak in a Gastrografin enema and/or CT scan without clinical signs of anastomotic leakage<br>2. Clinical leak: radiologic evidence of a leak in a Gastrografin enema and/or CT scan and/or sigmoidoscopy with one or more of the following clinical signs: elevated temperature (> 380C), leucocytosis, peritonitis, putrid or faecal discharge over the drainage or fistulas (recto-vaginal)
Secondary Outcome Measures
NameTimeMethod
1. Surgical complications related to primary surgery, to the stoma before closure and to secondary surgery for stoma closure<br>2. Postoperative mortality defined as death on account of any cause during the hospital stay due to the primary operation or stoma closure<br>3. The length of hospital stay in days for the primary operation and stoma closure
© Copyright 2025. All Rights Reserved by MedPath